Department of Cardiology, Austin Health, Melbourne, Victoria, Australia; Department of Medicine, The University of Melbourne, Victoria, Australia.
Department of Cardiology, Austin Health, Melbourne, Victoria, Australia.
Am J Med. 2020 Mar;133(3):311-322.e5. doi: 10.1016/j.amjmed.2019.07.057. Epub 2019 Aug 30.
New-onset postoperative atrial fibrillation is well recognized to be an adverse prognostic marker in patients undergoing noncardiac surgery. Whether postoperative atrial fibrillation confers an increased risk of stroke remains unclear.
A systematic review and meta-analysis was performed to assess the risk of stroke after postoperative atrial fibrillation in noncardiac surgery. MEDLINE, Cochrane, and EMBASE databases were searched for articles published up to May 2019 for studies of patients undergoing noncardiac surgery that reported incidence of new atrial fibrillation and stroke. Event rates from individual studies were pooled and risk ratios (RR) were pooled using a random-effects model.
Fourteen studies of 3,536,291 patients undergoing noncardiac surgery were included in the quantitative analysis (mean follow-up 1.4 ± 1 year). New atrial fibrillation occurred in 26,046 (0.74%), patients with a higher incidence following thoracic surgery. Stroke occurred in 279 (1.5%) and 6199 (0.4%) patients with and without postoperative atrial fibrillation, respectively. On pooled analysis, postoperative atrial fibrillation was associated with a significantly increased risk of stroke (RR 2.51; 95% confidence interval, 1.76-3.59), with moderate heterogeneity. The stroke risk was significantly higher with atrial fibrillation following nonthoracic, compared with thoracic, surgery (RR 3.09 vs RR 1.95; P = .01).
New postoperative atrial fibrillation following noncardiac surgery was associated with a 2.5-fold increase in the risk of stroke. This risk was highest among patients undergoing nonthoracic noncardiac surgery. Given the documented efficacy of newer anticoagulants, randomized controlled trials are warranted to assess whether they can reduce the risk of stroke in these patients.
新发性术后心房颤动是公认的非心脏手术患者的不良预后标志物。术后心房颤动是否会增加中风的风险尚不清楚。
进行了系统评价和荟萃分析,以评估非心脏手术后术后心房颤动后中风的风险。检索了截至 2019 年 5 月发表的关于接受非心脏手术且报告新发心房颤动和中风发生率的患者的 MEDLINE、Cochrane 和 EMBASE 数据库的文章。使用随机效应模型对来自个别研究的事件率进行汇总,并汇总风险比(RR)。
纳入了 14 项涉及 3536291 名接受非心脏手术患者的研究进行定量分析(平均随访 1.4±1 年)。26046 例(0.74%)患者出现新的心房颤动,其中胸部手术后发生率更高。发生中风 279 例(1.5%)和 6199 例(0.4%)患者分别有心房颤动和无术后心房颤动。荟萃分析显示,术后心房颤动与中风风险显著增加相关(RR 2.51;95%置信区间,1.76-3.59),存在中度异质性。与胸部手术后相比,非胸部手术后心房颤动的中风风险明显更高(RR 3.09 与 RR 1.95;P=.01)。
非心脏手术后新发术后心房颤动与中风风险增加 2.5 倍相关。这种风险在接受非胸部非心脏手术的患者中最高。鉴于新型抗凝剂的有效性已得到证实,需要进行随机对照试验来评估它们是否可以降低这些患者的中风风险。